Penumbra has initiated patient enrolment for a clinical trial of its Pulse flow restoration device, a temporary stent for the treatment of acute ischaemic stroke.
The clinical trial will evaluate the safety and effectiveness of aspiration with the Penumbra System, which is used for aspiration of the clot, in conjunction with the Pulse flow restoration device.
The Pulse device is a fully-retrievable, self-expanding and dense-mesh temporary stent that is designed to be deployed into clots that obstruct blood flow to the brain.
Once deployed, it restores blood flow to the brain and allows the simultaneous aspiration of clot by the means of the Penumbra System.
The trial will be conducted at the University Hospital Dresden in Dresden, Germany, and the University Hospital Göttingen in Göttingen, Germany.